Nancy Pelosi, the former Speaker of the House, often makes headlines for her stock trades.
Her husband, Paul Pelosi, a venture capitalist, is one of Washington’s most active traders.
💰 Stay ahead of the markets: Subscribe to TheStreet’s free daily newsletter💸
While she denies involvement in her husband’s trading decisions, their portfolio has seen some notable successes, including a profitable investment in Nvidia.
According to trading platform Autopilot, Pelosi’s portfolio delivered an impressive 54% gain in 2024, outperforming most hedge funds.
BREAKING: Pelosi did it 👑
She officially finishes 2024 up 54% and beat out Inverse Cramer for the top portfolio on Autopilot
Never doubt the queen of … pic.twitter.com/eT941WTdPs
— Nancy Pelosi Stock Tracker ♟ (@PelosiTracker_) January 2, 2025
On Jan. 17, she revealed some of her recent tradings in official filings just before Trump took office. One of the stocks she invested in surged more than 40% after the disclosure.
Nancy Pelosi has defended lawmakers making stock trades. She recently unveiled another position in her portfolio.
Win McNamee/Getty
What stock is Nancy Pelosi buying?
Pelosi purchased 50 call options (a bet that a stock will rise) for Tempus AIÂ (TEM) Â on Jan. 14, with a strike price of $20 per share. Each options contract typically represents 100 shares of the underlying stock.
Related: A popular congressman just bought these tech stocks
The overall trade value was between $50,000 and $100,000.
Tempus AI stock rallied more than 40% in two days following the disclosure.
Pelosi’s other investments included buying call options in Alphabet (GOOGL) , Amazon (AMZN) , Nvidia (NVDA) , power generation company Vistra (VST) , and cybersecurity firm Palo Alto Networks (PANW) .
Meanwhile, she sold some of her stakes in Nvidia and Apple on Dec. 31, 2024.
What does Tempus AI do?
Tempus AI is a health technology company founded in 2015. It is embedding AI into diagnostics to empower physicians and researchers to make personalized, data-driven decisions.
“The ability to deploy AI in precision medicine at scale has only recently become possible,” the company said in an SEC filing.
Related: Analyst who bet correctly in 2024 unveils top AI stock picks for 2025
“Advances in cloud computing, imaging technologies, large language models, and low-cost molecular profiling, along with the digitization of vast amounts of healthcare data, have created a landscape that we believe is finally ripe for AI.”
Tempus AI’s recent rally could also be driven by the launch of its AI-enabled personal health concierge app, Olivia. The app organizes patients’ health data in one place and uses AI to offer practical recommendations.
Tempus AI went public on June 14, 2024, with its initial public offering priced at $37 a share.
The company has not yet turned a profit. It reported losses of $290 million and $214 million for 2022 and 2023, respectively.
On Jan. 13, Tempus AI posted preliminary revenue for Q4 and full-year 2024.
The company expects FY24 revenue to reach $693 million, representing approximately 30% growth year-over-year.
This falls short of Wall Street analysts’ expectations of $716.98 million and is slightly lower than the higher end of the company’s projections in November.
Related: Analysts unveil Tempus AI stock price targets
The company’s projected Q4 revenue of $200 million also falls short of the consensus estimate of $206.07 million.
Loop Capital lowered Tempus AI’s price target to $52 from $57 with a buy rating following the preliminary results, citing the company’s below-consensus Q4 revenue pre-announcement, thefly.com reported.
Loop adds that Tempus AI also did not provide formal profitability guidance other than that it expects a sequential improvement in adjusted EBITDA in Q4.
Cathie Wood is also buying Tempus AI
Cathie Wood, head of Ark Investment Management, has also bought Tempus AI stock. She began investing in the stock after its June 24 IPO and has made several big purchases recently.
This month, for example, her Ark funds purchased 186,532 Tempus AI shares on Jan. 17, 378,883 on Jan. 13, and 53,376 on Jan. 3.
More 2025 stock market forecasts
Stocks face correction risk as Santa Claus Rally fails to deliverVeteran trader who correctly picked Palantir as top stock in ‘24 reveals best stock for ‘255 quantum computing stocks investors are targeting in 2025Goldman Sachs picks top sectors to own in 2025
That chunk of stocks is now worth roughly $31 million.
Tempus AI stock, now trading at $50.45, has lost about 38% since its November peak of $78.
Related: Veteran fund manager issues dire S&P 500 warning for 2025
